Question 1

What is Skyrizi (Risankizumab)?

Accepted Answer

Skyrizi (risankizumab) is a humanized monoclonal antibody that inhibits interleukin‑23A and is jointly developed by Boehringer Ingelheim and AbbVie for treating plaque psoriasis.

Question 2

How many companies research Skyrizi (Risankizumab)?

Accepted Answer

Based on our data, 13 companies research Skyrizi (Risankizumab). This number is updated daily as we discover new companies through job posting analysis.

Question 3

What types of companies research Skyrizi (Risankizumab)?

Accepted Answer

Skyrizi (Risankizumab) is relevant across multiple industries including Pharmaceutical Manufacturing, Hospitals and Health Care. Companies range from startups to enterprises with 10,000+ employees.

Question 4

How does TheirStack track companies related to Skyrizi (Risankizumab)?

Accepted Answer

TheirStack analyzes millions of job postings daily from company career pages, job boards, and recruitment platforms. When a company mentions Skyrizi (Risankizumab) in their job descriptions, requirements, or responsibilities, we identify them as related to Skyrizi (Risankizumab) and add them to our database.

Question 5

How can I get the full list of companies that research Skyrizi (Risankizumab)?

Accepted Answer

You can access the complete list of 13 companies on TheirStack. The data includes company name, industry, size, location, funding, and revenue. Available via our web app or API.

Question 6

How often is the company data updated?

Accepted Answer

Our database is refreshed daily. We continuously monitor job postings to detect new companies researching Skyrizi (Risankizumab) and update existing records.

Company	Country	Industry	Employees	Revenue	Technologies
AbbVie	United States	Pharmaceutical Manufacturing	62k	$26B	Skyrizi (Risankizumab)
US Digestive Health	United States	Hospitals and Health Care	267	$25M	Skyrizi (Risankizumab)
CSI Pharmacy	United States	Hospitals and Health Care	310		Skyrizi (Risankizumab)
MNGI Digestive Health	United States	Hospitals and Health Care	501	$100M	Skyrizi (Risankizumab)
CarepathRx	United States	Hospitals and Health Care	1k		Skyrizi (Risankizumab)
Gastroenterology Specialties, PC	United States	Hospitals and Health Care	201	$12M	Skyrizi (Risankizumab)

Companies researching Skyrizi (Risankizumab)

List of companies that research Skyrizi (Risankizumab)